Copyright
©The Author(s) 2020.
World J Diabetes. Dec 15, 2020; 11(12): 654-665
Published online Dec 15, 2020. doi: 10.4239/wjd.v11.i12.654
Published online Dec 15, 2020. doi: 10.4239/wjd.v11.i12.654
Table 2 Blood glucose level and time in range at baseline and 12 wk [mean ± SD or median (interquartile range)]
| Variable | Baseline | 12 wk | P value |
| eHbA1c (%) | 8.4 ± 1.4 | 7.0 ± 1.3 | 0.003 |
| MBG (mmol/L) | 10.8 ± 2.3 | 8.6 ± 2.0 | 0.003 |
| TIR (h) | 6.1 ± 5.9 | 11.5 ± 5.8 | 0.005 |
| TOR (h) | 17.9 ± 5.9 | 12.5 ± 5.8 | 0.005 |
- Citation: Li Y, Han MM, He Q, Liu ZA, Liang D, Hou JT, Zhang Y, Liu YF. Exenatide once weekly combined with metformin reduced glycemic variability in type 2 diabetes by using flash glucose monitoring system. World J Diabetes 2020; 11(12): 654-665
- URL: https://www.wjgnet.com/1948-9358/full/v11/i12/654.htm
- DOI: https://dx.doi.org/10.4239/wjd.v11.i12.654